167 related articles for article (PubMed ID: 34408224)
21. Activity of a broad-spectrum cephalosporin (Ro 48-8391) alone and in combination with two novel beta-lactamase inhibitors (Ro 48-5545 and Ro 48-8724).
Jones RN; Marshall SA; Varnam DJ
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):85-94. PubMed ID: 9823530
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of β-cell antibodies and associated autoimmune diseases in children and adolescents with type 1 diabetes (T1DM) versus type 2 diabetes (T2DM) in Qatar.
Alyafei F; Soliman A; Alkhalaf F; Sabt A; De Sanctis V; Elsayed N; Waseef R
Acta Biomed; 2018 May; 89(S5):32-39. PubMed ID: 30049930
[TBL] [Abstract][Full Text] [Related]
23. Combination beta-lactam and beta-lactamase-inhibitor products: antimicrobial activity and efficiency of enzyme inhibition.
Rotschafer JC; Ostergaard BE
Am J Health Syst Pharm; 1995 Mar; 52(6 Suppl 2):S15-22. PubMed ID: 7606585
[TBL] [Abstract][Full Text] [Related]
24. Newer penicillins and beta-lactamase inhibitors.
Bush LM; Calmon J; Johnson CC
Infect Dis Clin North Am; 1989 Sep; 3(3):571-94. PubMed ID: 2671140
[TBL] [Abstract][Full Text] [Related]
25. The frequency of Klebsiella pneumonia encoding genes for CTX-M, TEM-1 and SHV-1 extended-spectrum beta lactamases enzymes isolated from urinary tract infection.
Dehshiri M; Khoramrooz SS; Zoladl M; Khosravani SA; Parhizgari N; Motazedian MH; Jahedi S; Sharifi A
Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):4. PubMed ID: 29433582
[TBL] [Abstract][Full Text] [Related]
26. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.
French GL; Shannon KP; Simmons N
J Clin Microbiol; 1996 Feb; 34(2):358-63. PubMed ID: 8789016
[TBL] [Abstract][Full Text] [Related]
27. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
28. Designing Inhibitors of β-Lactamase Enzymes to Overcome Carbapenem Resistance in Gram-Negative Bacteria.
Davies DT; Everett M
Acc Chem Res; 2021 May; 54(9):2055-2064. PubMed ID: 33788541
[TBL] [Abstract][Full Text] [Related]
29. Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections.
Liu B; Trout REL; Chu GH; McGarry D; Jackson RW; Hamrick JC; Daigle DM; Cusick SM; Pozzi C; De Luca F; Benvenuti M; Mangani S; Docquier JD; Weiss WJ; Pevear DC; Xerri L; Burns CJ
J Med Chem; 2020 Mar; 63(6):2789-2801. PubMed ID: 31765155
[TBL] [Abstract][Full Text] [Related]
30. Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.
Lister PD
Pharmacotherapy; 2000 Sep; 20(9 Pt 2):213S-218S; discussion 224S-228S. PubMed ID: 11001328
[TBL] [Abstract][Full Text] [Related]
31. Apalcillin [PC-904]: spectrum of activity and beta-lactamase hydrolysis/inhibition.
Barry AL; Jones RN; Thornsberry C
Diagn Microbiol Infect Dis; 1985 Jan; 3(1):7-17. PubMed ID: 3871382
[TBL] [Abstract][Full Text] [Related]
32. Beta-lactamases and beta-lactamase inhibitors.
Williams JD
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 1():S3-7; discussion S26-7. PubMed ID: 10526867
[TBL] [Abstract][Full Text] [Related]
33. Recent advances in the development of β-lactamase inhibitors.
Jalde SS; Choi HK
J Microbiol; 2020 Aug; 58(8):633-647. PubMed ID: 32720096
[TBL] [Abstract][Full Text] [Related]
34. Evolution of beta-lactamase inhibitors.
Livermore DM
Intensive Care Med; 1994 Jul; 20 Suppl 3():S10-3. PubMed ID: 7962983
[TBL] [Abstract][Full Text] [Related]
35. 'Beta-lactams' as beta-lactamase inhibitors.
Cole M
Philos Trans R Soc Lond B Biol Sci; 1980 May; 289(1036):207-23. PubMed ID: 6109317
[TBL] [Abstract][Full Text] [Related]
36. Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors.
Kitzis MD; Billot-Klein D; Goldstein FW; Williamson R; Tran Van Nhieu G; Carlet J; Acar JF; Gutmann L
Antimicrob Agents Chemother; 1988 Jan; 32(1):9-14. PubMed ID: 2831817
[TBL] [Abstract][Full Text] [Related]
37. Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases.
Lomovskaya O; Tsivkovski R; Nelson K; Rubio-Aparicio D; Sun D; Totrov M; Dudley MN
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229489
[TBL] [Abstract][Full Text] [Related]
38. Beta-lactamase inhibitors: agents to overcome bacterial resistance.
Maiti SN; Phillips OA; Micetich RG; Livermore DM
Curr Med Chem; 1998 Dec; 5(6):441-56. PubMed ID: 9873109
[TBL] [Abstract][Full Text] [Related]
39. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein.
Laugesen M; Elliott R
N Z Med J; 2003 Jan; 116(1168):U295. PubMed ID: 12601419
[TBL] [Abstract][Full Text] [Related]
40. An ecological analysis of childhood-onset type 1 diabetes incidence and prevalence in Latin America.
Collado-Mesa F; Barceló A; Arheart KL; Messiah SE
Rev Panam Salud Publica; 2004 Jun; 15(6):388-94. PubMed ID: 15272985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
